Is PT-141 Legal? Global Status Guide
Category: Sexual Health · Tracked in 159 countries
29
Legal123
Grey Area4
Prescription3
BannedCan You Buy PT-141?
Whether you can buy PT-141 depends on your country. It is legal to purchase in 29 countries, including Anguilla, Antigua and Barbuda, Aruba, Bahamas, Barbados, Bosnia and Herzegovina, British Virgin Islands, Cayman Islands, and 21 more. A prescription is required in 4 countries, including Australia, New Zealand, United Arab Emirates, United States. It falls into a legal grey area in 123 countries (Algeria, Andorra, Angola, Argentina, Austria, Bahrain, Bangladesh, Belgium, and 115 more), where it may be available for research but not for human use. It is banned in 3 countries: Cuba, Saudi Arabia, Singapore.
Traveling with PT-141
Traveling internationally with PT-141 requires understanding local laws at your destination. Do not carry PT-141 into countries where it is banned (Cuba, Saudi Arabia, Singapore) — you could face serious legal consequences. In countries requiring a prescription (Australia, New Zealand, United Arab Emirates, United States), carry a valid prescription or doctor's letter. Always declare pharmaceutical products at customs and check the latest regulations before traveling.
Need to calculate your PT-141 dosage? Use the PT-141 reconstitution calculator on peptide.locker
PT-141 Legal Status by Country (159)
| Country | Status | Rx Required | Schedule | Detail |
|---|---|---|---|---|
| Anguilla | Legal | No | Not Scheduled | — |
| Antigua and Barbuda | Legal | No | Not Scheduled | — |
| Aruba | Legal | No | Not Scheduled | — |
| Bahamas | Legal | No | Not Scheduled | — |
| Barbados | Legal | No | Not Scheduled | — |
| Bosnia and Herzegovina | Legal | No | Not Scheduled | — |
| British Virgin Islands | Legal | No | Not Scheduled | — |
| Cayman Islands | Legal | No | Not Scheduled | — |
| Costa Rica | Legal | No | Not Scheduled | — |
| Curacao | Legal | No | Not Scheduled | — |
| Dominica | Legal | No | Not Scheduled | — |
| Dominican Republic | Legal | No | Not Scheduled | — |
| Georgia | Legal | No | Not Scheduled | — |
| Grenada | Legal | No | Not Scheduled | — |
| Jamaica | Legal | No | Not Scheduled | — |
| Montenegro | Legal | No | Not Scheduled | — |
| Montserrat | Legal | No | Not Scheduled | — |
| North Macedonia | Legal | No | Not Scheduled | — |
| Papua New Guinea | Legal | No | Not Scheduled | — |
| Samoa | Legal | No | Not Scheduled | — |
| Serbia | Legal | No | Not Scheduled | — |
| St Kitts and Nevis | Legal | No | Not Scheduled | — |
| St Lucia | Legal | No | Not Scheduled | — |
| St Vincent and the Grenadines | Legal | No | Not Scheduled | — |
| Tonga | Legal | No | Not Scheduled | — |
| Trinidad and Tobago | Legal | No | Not Scheduled | — |
| Turks and Caicos | Legal | No | Not Scheduled | — |
| Ukraine | Legal | No | Not Scheduled | — |
| Vanuatu | Legal | No | Not Scheduled | — |
| Algeria | Grey Area | No | Unregistered | — |
| Andorra | Grey Area | No | Unregistered | — |
| Angola | Grey Area | No | Unregistered | — |
| Argentina | Grey Area | No | Unregistered | — |
| Austria | Grey Area | No | Unregistered | — |
| Bahrain | Grey Area | No | Unregistered | — |
| Bangladesh | Grey Area | No | Unregistered | — |
| Belgium | Grey Area | No | Unregistered | — |
| Belize | Grey Area | No | Unregistered | — |
| Bolivia | Grey Area | No | Unregistered | — |
| Bonaire | Grey Area | No | Unregistered | — |
| Botswana | Grey Area | No | Unregistered | — |
| Brazil | Grey Area | No | Unregistered | Not ANVISA-approved. |
| Brunei | Grey Area | No | Unregistered | — |
| Bulgaria | Grey Area | No | Unregistered | — |
| Cambodia | Grey Area | No | Unregistered | — |
| Cameroon | Grey Area | No | Unregistered | — |
| Canada | Grey Area | No | Unauthorized Medicine | Not approved by Health Canada. No DIN. |
| Cape Verde | Grey Area | No | Unregistered | — |
| Chile | Grey Area | No | Unregistered | — |
| China | Grey Area | No | Not Scheduled | Not NMPA-approved. Chinese manufacturers produce bulk API for export. |
| Colombia | Grey Area | No | Unregistered | — |
| Croatia | Grey Area | No | Unregistered | — |
| Cyprus | Grey Area | No | Unregistered | — |
| Czech Republic | Grey Area | No | Unregistered | — |
| Democratic Republic of Congo | Grey Area | No | Unregistered | — |
| Denmark | Grey Area | No | Unregistered | — |
| Ecuador | Grey Area | No | Unregistered | — |
| Egypt | Grey Area | No | Unregistered | — |
| El Salvador | Grey Area | No | Unregistered | — |
| Estonia | Grey Area | No | Unregistered | — |
| Ethiopia | Grey Area | No | Unregistered | — |
| Fiji | Grey Area | No | Unregistered | — |
| Finland | Grey Area | No | Unregistered | — |
| France | Grey Area | No | Unregistered | — |
| French Guiana | Grey Area | No | Unregistered | — |
| Germany | Grey Area | No | Not Scheduled / Unauthorized | Not EMA-authorized. Unauthorized medicinal product under AMG. |
| Ghana | Grey Area | No | Unregistered | — |
| Greece | Grey Area | No | Unregistered | — |
| Guatemala | Grey Area | No | Unregistered | — |
| Guyana | Grey Area | No | Unregistered | — |
| Honduras | Grey Area | No | Unregistered | — |
| Hong Kong | Grey Area | No | Unregistered | — |
| Hungary | Grey Area | No | Unregistered | — |
| Iceland | Grey Area | No | Unregistered | — |
| India | Grey Area | No | Not Scheduled | Not CDSCO-approved. Indian manufacturers produce API for export. |
| Indonesia | Grey Area | No | Unregistered | — |
| Iran | Grey Area | No | Unregistered | — |
| Iraq | Grey Area | No | Unregistered | — |
| Ireland | Grey Area | No | Unregistered | — |
| Israel | Grey Area | No | Unregistered | — |
| Italy | Grey Area | No | Unregistered | — |
| Ivory Coast | Grey Area | No | Unregistered | — |
| Japan | Grey Area | No | Not Scheduled | Not PMDA-approved. |
| Jordan | Grey Area | No | Unregistered | — |
| Kenya | Grey Area | No | Unregistered | — |
| Kuwait | Grey Area | No | Unregistered | — |
| Laos | Grey Area | No | Unregistered | — |
| Latvia | Grey Area | No | Unregistered | — |
| Lebanon | Grey Area | No | Unregistered | — |
| Libya | Grey Area | No | Unregistered | — |
| Liechtenstein | Grey Area | No | Unregistered | — |
| Lithuania | Grey Area | No | Unregistered | — |
| Luxembourg | Grey Area | No | Unregistered | — |
| Madagascar | Grey Area | No | Unregistered | — |
| Malawi | Grey Area | No | Unregistered | — |
| Malaysia | Grey Area | No | Unregistered | — |
| Maldives | Grey Area | No | Unregistered | — |
| Malta | Grey Area | No | Unregistered | — |
| Mauritius | Grey Area | No | Unregistered | — |
| Mexico | Grey Area | No | Unregistered | Not COFEPRIS-approved. |
| Monaco | Grey Area | No | Unregistered | — |
| Morocco | Grey Area | No | Unregistered | — |
| Mozambique | Grey Area | No | Unregistered | — |
| Myanmar | Grey Area | No | Unregistered | — |
| Namibia | Grey Area | No | Unregistered | — |
| Nepal | Grey Area | No | Unregistered | — |
| Netherlands | Grey Area | No | Unregistered | — |
| Nicaragua | Grey Area | No | Unregistered | — |
| Nigeria | Grey Area | No | Unregistered | — |
| Norway | Grey Area | No | Unregistered | — |
| Oman | Grey Area | No | Unregistered | — |
| Pakistan | Grey Area | No | Unregistered | — |
| Panama | Grey Area | No | Unregistered | — |
| Paraguay | Grey Area | No | Unregistered | — |
| Peru | Grey Area | No | Unregistered | — |
| Philippines | Grey Area | No | Unregistered | — |
| Poland | Grey Area | No | Unregistered | — |
| Portugal | Grey Area | No | Unregistered | — |
| Puerto Rico | Grey Area | No | Unregistered | — |
| Qatar | Grey Area | No | Unregistered | — |
| Romania | Grey Area | No | Unregistered | — |
| Russia | Grey Area | No | Unregistered | — |
| Rwanda | Grey Area | No | Unregistered | — |
| Saba | Grey Area | No | Unregistered | — |
| Saint Barthelemy | Grey Area | No | Unregistered | — |
| Saint Martin (French) | Grey Area | No | Unregistered | — |
| Senegal | Grey Area | No | Unregistered | — |
| Seychelles | Grey Area | No | Unregistered | — |
| Sint Eustatius | Grey Area | No | Unregistered | — |
| Sint Maarten | Grey Area | No | Unregistered | — |
| Slovakia | Grey Area | No | Unregistered | — |
| Slovenia | Grey Area | No | Unregistered | — |
| South Africa | Grey Area | No | Unregistered | — |
| South Korea | Grey Area | No | Unregistered | — |
| Spain | Grey Area | No | Unregistered | — |
| Sri Lanka | Grey Area | No | Unregistered | — |
| Suriname | Grey Area | No | Unregistered | — |
| Sweden | Grey Area | No | Unregistered | — |
| Switzerland | Grey Area | No | Unregistered | — |
| Taiwan | Grey Area | No | Unregistered | — |
| Tanzania | Grey Area | No | Unregistered | — |
| Thailand | Grey Area | No | Unregistered | — |
| Tunisia | Grey Area | No | Unregistered | — |
| Turkey | Grey Area | No | Unregistered | — |
| Uganda | Grey Area | No | Unregistered | — |
| United Kingdom | Grey Area | No | Not Scheduled / Unauthorized | Not licensed by MHRA. No approved pharmaceutical product. Available only through grey-market peptide suppliers. |
| Uruguay | Grey Area | No | Unregistered | — |
| US Virgin Islands | Grey Area | No | Unregistered | — |
| Venezuela | Grey Area | No | Unregistered | — |
| Vietnam | Grey Area | No | Unregistered | — |
| Zambia | Grey Area | No | Unregistered | — |
| Zimbabwe | Grey Area | No | Unregistered | — |
| Australia | Prescription | Yes | Schedule 4 | Not TGA-approved (not on ARTG). Access possible via Special Access Scheme or Authorised Prescriber pathway. |
| New Zealand | Prescription | Yes | Schedule 4 | — |
| United Arab Emirates | Prescription | Yes | Unapproved (Rx Required) | — |
| United States | Prescription | Yes | Not Scheduled | FDA-approved: Vyleesi (bremelanotide, June 2019) for HSDD in premenopausal women only. Not a controlled substance. Category 2 (do-not-compound). HHS announced Feb 2026 potential reclassification to Category 1 (pending). |
| Cuba | Banned | No | State Controlled | — |
| Saudi Arabia | Banned | No | State Controlled | — |
| Singapore | Banned | No | State Controlled | — |
Data is researcher-verified but not legal advice. Regulations change frequently. Always verify with local authorities before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.